[Lipid peroxidation in patients with nephrolithiasis and chronic pyelonephritis in the remission stage].
Lipid peroxidation (LPO) was evaluated in 31 patients with nephrolithiasis and chronic pyelonephritis in remission. Chronic inflammation of renal parenchyma is shown to be associated with LPO activation. Urine diene conjugates excretion, plasma and red cell membrane malonic dialdehyde concentrations increase. LPO activation may contribute to maintenance of chronic renal inflammation in nephrolithiasis.
Golovanov
S A
SA
Drozhzheva
V V
VV
D000328:Adult; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007669:Kidney Calculi / Q000378:metabolism* / Q000628:therapy; D015227:Lipid Peroxidation; D008054:Lipid Peroxides / Q000032:analysis; D008297:Male; D008315:Malondialdehyde / Q000032:analysis; D008875:Middle Aged; D011704:Pyelonephritis / Q000378:metabolism* / Q000628:therapy; D012074:Remission Induction
D008054:Lipid Peroxides; D008315:Malondialdehyde
Sostoianie perekisnogo okisleniia lipidov u bol'nykh nefrolitiazom i khronicheskim pielonefritom v stadii remissii.